No hours-long drip, it’s a 7-min shot: Roche brings world’s 1st under-the-skin lung cancer drug to India
NN
Nursing News Desk
Roche was granted a Phase 3 clinical trial waiver by CDSCO last year for the Indian launch of Tecentriq SC. The Swiss pharma giant is committed to conducting a post-market study in India.